Navigation Links
Volcano Corporation Reports Preliminary Third Quarter 2007 Revenues

SAN DIEGO, Oct. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) announced today that it expects record revenues of approximately $31.5 million for the third quarter ended September 30, 2007. The company said that the preliminary third quarter revenues represent a 28 percent increase in the sales of its Intravascular Ultrasound (IVUS) disposables in the United States year-over-year and an overall increase of 24 percent in sales of IVUS disposables versus the third quarter of 2006.

Further details of the company's third quarter and full-year operating and financial performance will be released later this quarter, which will be followed by a conference call and web cast open to all interested parties. Details of the earnings release date, conference call and web cast will be provided in a subsequent release. The final revenues for the third quarter of 2007 may differ from the preliminary results discussed above due to factors that include, but are not limited to, risks associated with final review of the results and preparation of quarterly financial statements.

Volcano Corporation offers a broad suite of devices designed to facilitate endovascular procedures and enhance the diagnosis of vascular and structural heart diseases and guide therapies.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding Volcano's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, statements concerning Volcano's expected revenues for the third quarter ended September 30, 2007 are forward-looking statements involving risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially from the statements contained herein. The potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's reports and other filings made with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. Volcano Corporation expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Volcano Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Envisat Captured Breath of Volcano
2. Furore Over Spa Planned on Active Philippines Volcano
3. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
4. Autopsy reports could be valuable and informative
5. China reports declining number of SARS Cases
6. Russia Reports First SARS Case
7. Research reports that c-section deliveries are rising
8. Jharkhand reports 13,000 Malaria cases
9. Uganda Reports Failure To Contain Sleeping Sickness
10. WHO reports 36 million deaths world wide due to chronic diseases
11. Reports of Hantavirus infection in India raise concerns
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... An increasing number ... Association (FAA) has partnered with the Florida Department of Health and its Bureau ... The FAA Smoke-Free Multifamily Housing Program launched last week at the organization’s 2015 ...
(Date:10/13/2015)... ... 13, 2015 , ... Bambeco, Inc., the premier brand for ... it closed on a $20.5 million funding round led by ABS Capital Partners, ... Company’s continued rapid growth and expansion, broaden the Company’s product offerings, and expand ...
(Date:10/13/2015)... Los Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... game. To incentivize would-be customers, eMarketing Concepts began a $1 promotion – effectively offering ... was a resounding success, and within weeks the company was flooded with phone calls ...
(Date:10/13/2015)... ... October 13, 2015 , ... SPH Analytics today announced the ... organization’s Executive Vice President of Operations, and three Senior Vice Presidents, Robert Davis, ... the company. , Debbie Vereb’s appointment to Executive Vice President of Operations at ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... a new PDF automation tool to batch conversions of CAD drawings, plans, ... 100% document fidelity. , CADConverter eliminates the complexity requirement of specialized applications to ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 13, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... Cell Therapy Catapult to advance development of large ... cell immunotherapy. Under the agreement, the Cell Therapy ... AST-VAC2 to support advanced clinical trials and eventual ... --> The Cell Therapy Catapult is ...
(Date:10/12/2015)... 13, 2015 the United States ... a non-clinical capacity. --> the United States ... a non-clinical capacity. --> The University of Texas MD ... the first high field (1.5 Tesla) MRI-guided linear accelerator in ... system will be operating in a non-clinical capacity. Royal ...
(Date:10/12/2015)... 2015 Given the intricacy of the ... to deliver an ophthalmic drug effectively to a specific ocular ... ocular drug delivery. These include dilution of a drug by ... conjunctiva and drug permeation issues with respect to the cornea, ... eye drops, is lost due to the aforementioned barriers. ...
Breaking Medicine Technology: